IP Group has poured more funding into Istesso, whose treatment for rheumatoid arthritis traces its roots to an Aberdeen spinout, to drive immuno-metabolism therapies for autoimmune diseases.
Backed by investors including BDC Capital, Toronto-founded Blue J Legal hopes to adapt its legal forecasting technology to the US system.
Streem, a home services AR software developer whose shareholders include Oregon State University-backed Rogue Venture Partners, is raising a second funding round.
The KCL immuno-oncology spinout’s second series A close included investment from UCL Technology Fund, Alsa Holding and Epidarex Capital.
Loyalty Prime has been backed by the VC affiliate of Technical University of Munich’s Unternehmertum as it builds the international profile of its loyalty scheme management software.
UCL spinout Engitix plans to develop therapeutics for liver fibrosis and certain cancers based on its targeted drug discovery platform.
Harvard’s Quralis has added funding from investors including Viva Biotech to take its seed total to $5.5m as it looks to advance treatments for amyotrophic lateral sclerosis to the clinic.
4490 Ventures has returned for the latest round for weather analytics service Understory, which has disclosed a total of $24.6m in funding to date.